Pancreatic | Cases from the Community: Clinical Investigators Provide Perspectives on Actual Patients with Pancreatic Cancer
Manage episode 229815206 series 1464173
Faculty presentations from a CME symposium held at the 2019 Gastrointestinal Cancers Symposium. Featuring perspectives from Drs Andrew E Hendifar, Eileen M O’Reilly, Philip A Philip and Margaret A Tempero:
- Available and Emerging Research Guiding the Treatment of Resectable or Borderline Resectable Pancreatic Adenocarcinoma (PAD) — Dr Tempero (0:00)
- Patient- and Disease-Specific Factors Informing the Selection of Therapy for Locally Advanced, Unresectable PAD; Selection of First-Line Treatment for Metastatic Disease — Dr Philip (8:24)
- Optimal Management of Metastatic Disease After Progression on First-Line Therapy — Dr O’Reilly (17:24)
- Novel Agents and Strategies Under Investigation — Dr Hendifar (25:21)
2149 episodes available. A new episode about every 2 days averaging 64 mins duration .